<p>An <i>S</i> and <i>M</i> indicate pathway differential expression significance of <i>p</i>< = 0.05 and marginal significance of <i>p</i>< = 0.1, respectively. Italic text indicates previously discovered associations between the pathway and COPD. Non-italic text indicates no known associations between the pathway and COPD.</p>*<p>Arginine and pyrimidine are used therapeutically to treat COPD. Specific p-values are found in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002967#pcbi.1002967.s016" target="_blank">Table S6</a>.</p
Background: COPD is a heterogeneous chronic inflammatory disease of the airways and it is well accep...
International audienceObjective Novel biomarkers related to main clinical hallmarks of Chronic obstr...
BACKGROUND: Identifying protein biomarkers for chronic obstructive pulmonary disease (COPD) has been...
Rationale COPD is influenced by many genetic and environmental factors. Genetic studies provided ins...
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and t...
Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung p...
Rationale: Although cigarette smoking is the most important risk factor for COPD, COPD develops in o...
Chronic obstructive pulmonary disease (COPD) is a disorder characterized by chronic inflammation of ...
Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung p...
Detection of proteins which may be potential biomarkers of disorders represents a big step forward i...
Stable COPD patients (n = 241) were included in the COBRA cohort at visit 1 and serum SOMAscan analy...
COPD is a heterogeneous disorder that shows diverse clinical presentations (phenotypes and "treatabl...
The integration of transcriptomic and proteomic data from lung tissue with chronic obstructive pulmo...
BACKGROUND: Lung fibroblasts are implicated in abnormal tissue repair in chronic obstructive pulmona...
The identification and validation of biomarkers to support the assessment of novel therapeutics for ...
Background: COPD is a heterogeneous chronic inflammatory disease of the airways and it is well accep...
International audienceObjective Novel biomarkers related to main clinical hallmarks of Chronic obstr...
BACKGROUND: Identifying protein biomarkers for chronic obstructive pulmonary disease (COPD) has been...
Rationale COPD is influenced by many genetic and environmental factors. Genetic studies provided ins...
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and t...
Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung p...
Rationale: Although cigarette smoking is the most important risk factor for COPD, COPD develops in o...
Chronic obstructive pulmonary disease (COPD) is a disorder characterized by chronic inflammation of ...
Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung p...
Detection of proteins which may be potential biomarkers of disorders represents a big step forward i...
Stable COPD patients (n = 241) were included in the COBRA cohort at visit 1 and serum SOMAscan analy...
COPD is a heterogeneous disorder that shows diverse clinical presentations (phenotypes and "treatabl...
The integration of transcriptomic and proteomic data from lung tissue with chronic obstructive pulmo...
BACKGROUND: Lung fibroblasts are implicated in abnormal tissue repair in chronic obstructive pulmona...
The identification and validation of biomarkers to support the assessment of novel therapeutics for ...
Background: COPD is a heterogeneous chronic inflammatory disease of the airways and it is well accep...
International audienceObjective Novel biomarkers related to main clinical hallmarks of Chronic obstr...
BACKGROUND: Identifying protein biomarkers for chronic obstructive pulmonary disease (COPD) has been...